EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease—a Danish explorative study

Thea Vestergaard, Mette Julsgaard, Rikke Bek Helmig, Emilie Faunø, Tau Vendelboe, Jens Kelsen, Trine Bay Laurberg, Anne Sørensen, Bodil Ginnerup Pedersen

Clinical Rheumatology · 2024

DOI: 10.1007/s10067-024-06889-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Thea Vestergaard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens, Boulevard 99, Entrance C, Level 1, Fix-Point C117, 820…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Placenta, Birth Weight, Rheumatic Diseases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sundhedsvidenskabelige Fakultet, Aarhus Universitet, Gigtforeningen, Colitis-Crohn Foreningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Women with chronic rheumatic disease (CRD) are at greater risk of foetal growth restriction than their healthy peers. T2*-weighted magnetic resonance imaging of placenta (T2*P-MRI) is superior to conventional ultrasonography in predicting birth weight and works as a proxy metabolic mirror of the placental function. We aimed to compare T2*P-MRI in pregnant women with CRD and healthy controls. In addition, we aimed to investigate the correlation between T2*P-MRI and birth weight.

Methods

Using a General Electric (GE) 1.5 Tesla, we consecutively performed T2*-weighted placental MRI in 10 women with CRD and 18 healthy controls at gestational week (GW)24 and GW32. We prospectively collected clinical parameters during pregnancy including birth outcome and placental weight.

Results

Women with CRD had significantly lower T2*P-MRI values at GW24 than healthy controls (median T2*(IQR) 92.1 ms (81.6; 122.4) versus 118.6 ms (105.1; 129.1), p = 0.03). T2*P-MRI values at GW24 showed a significant correlation with birth weight, as the T2*P-MRI value was reduced in all four pregnancies complicated by SGA at birth. Three out of four pregnancies complicated by SGA at birth remained undetected by routine antenatal ultrasound.

Conclusion

This study demonstrates reduced T2*P-MRI values and a high proportion of SGA at birth in CRD pregnancies compared to controls, suggesting an increased risk of placental dysfunction in CRD pregnancies. T2*P-MRI may have the potential to focus clinical vigilance by identifying pregnancies at risk of SGA as early as GW24. Key Points • Placenta-related causes of foetal growth restriction in women with rheumatic disease remain to be investigated .• T2*P-MRI values at gestational week 24 predicted foetuses small for gestational age at birth .• T2*P-MRI may indicate pregnant women with chronic rheumatic disease (CRD) in need of treatment optimization .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingPlacentaBirth WeightRheumatic DiseasesHumansPregnancyAdultInfant, Small for Gestational AgeCase-Control StudiesDenmarkPregnancy ComplicationsProspective StudiesMaleFemale

Stichwörter der Autor:innen

Foetal growth restrictionMRIPlacental dysfunctionPregnancyRheumatology

Autor:innen und Institutionen

  • Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens, Boulevard 99, Entrance C, Level 1, Fix-Point C117, 8200, Aarhus, Denmark. theakalender@gmail.dk.
  • Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark. theakalender@gmail.dk.
  • Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens, Boulevard 99, Entrance C, Level 1, Fix-Point C117, 8200, Aarhus, Denmark.
  • Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Department of Clinical Medicine, Aalborg University, Aalborg, Copenhagen, Denmark.
  • Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.

Förderung

  • Sundhedsvidenskabelige Fakultet, Aarhus Universitet
  • Gigtforeningen
  • Colitis-Crohn Foreningen
  • Aage og Johanne Louis-Hansens Fond
  • Aase og Ejnar Danielsens Fond
  • Fonden til Lægevidenskabens Fremme
  • Aarhus University Hospital

Zitieren

APA

Vestergaard, T., Julsgaard, M., Helmig, R. B., Faunø, E., Vendelboe, T., Kelsen, J., Laurberg, T. B., Sørensen, A., & Pedersen, B. G. (2024). Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease—a Danish explorative study. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-06889-5

Vancouver

Vestergaard T, Julsgaard M, Helmig RB, Faunø E, Vendelboe T, Kelsen J, et al. Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease—a Danish explorative study. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-06889-5

BibTeX
@article{Vestergaard2024,
  author = {Vestergaard, Thea and Julsgaard, Mette and Helmig, Rikke Bek and Faunø, Emilie and Vendelboe, Tau and Kelsen, Jens and Laurberg, Trine Bay and Sørensen, Anne and Pedersen, Bodil Ginnerup},
  title = {Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease—a Danish explorative study},
  journal = {Clinical Rheumatology},
  year = {2024},
  doi = {10.1007/s10067-024-06889-5}
}
Kostenlos starten →